A Review of Direct Oral Anticoagulants in Patients With Stage 5 or End-Stage Kidney Disease.

Jessica A Starr Nathan A PinnerMelanie MannisMary Katherine Stuart

Published in: The Annals of pharmacotherapy (2021)

If OACs for stroke prevention with AF are deemed necessary, apixaban or rivaroxaban can be considered. DOACs cannot currently be recommended over warfarin in patients with CKD-5 or ESKD and VTE.

Keyphrases

direct oral anticoagulants
atrial fibrillation
venous thromboembolism
chronic kidney disease
oral anticoagulants
pulmonary embolism
subarachnoid hemorrhage